(BMRN) Biomarin Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biomarin Pharmaceutical | (BMRN) share price targets
Complete technical analysis of Biomarin Pharmaceutical (BMRN) by charts plus indicators, forecast predictions and share price targets for Biomarin Pharmaceutical (BMRN)
Biomarin Pharmaceutical trades in USA in Health Care sector.
10 day averaged volume of Biomarin Pharmaceutical is 1735860
Date | Daily Closing Price | Open | High | Low | Volume |
29 Fri Aug 2025 | 58.27 | 57.54 | 58.35 | 57.30 | 0.731 times |
28 Thu Aug 2025 | 57.68 | 58.47 | 58.64 | 57.32 | 0.717 times |
27 Wed Aug 2025 | 58.66 | 57.50 | 58.80 | 57.42 | 0.98 times |
26 Tue Aug 2025 | 57.45 | 58.65 | 58.72 | 57.15 | 1.277 times |
25 Mon Aug 2025 | 58.50 | 58.88 | 58.94 | 57.55 | 0.991 times |
22 Fri Aug 2025 | 58.58 | 58.23 | 58.85 | 57.74 | 0.953 times |
21 Thu Aug 2025 | 58.07 | 57.48 | 58.68 | 57.44 | 0.811 times |
20 Wed Aug 2025 | 57.96 | 57.50 | 58.70 | 57.27 | 1.016 times |
19 Tue Aug 2025 | 57.31 | 57.80 | 58.14 | 57.16 | 0.826 times |
18 Mon Aug 2025 | 57.44 | 57.68 | 58.35 | 57.31 | 0.974 times |
My analysis of stock is bullish for shortterm, and stock might move up till 59.5 or till 60.9. Use a stoploss of 58.25 and if this stock hits its stoploss, then it can fall down till 57.04
Share price targets for Biomarin Pharmaceutical (BMRN)
Target Type | Value |
Downside Target | 52.93 |
Downside Target | 56.36 |
Upside Target | 58.59 |
Upside Target | 58.94 |
Upside Target | 59.09 |
Upside Target | 59.62 |
Upside Target | 60.43 |
Upside Target | 63.97 |
Upside Target | 65.40 |
Upside Target | 70.63 |
Intraday share price targets for Biomarin Pharmaceutical (BMRN)
Target Type | Value |
Downside Intraday Target | 57.3 |
Downside Intraday Target | 56.33 |
Upside Intraday Target | 59.09 |
Upside Intraday Target | 59.91 |
Downside Intraday Target | 58.12 |
Weekly technical analysis of Biomarin Pharmaceutical (BMRN)
Date | Weekly Closing Price | Open | High | Low | Volume |
29 Fri Aug 2025 | 58.27 | 58.88 | 58.94 | 57.15 | 1.025 times |
22 Fri Aug 2025 | 58.58 | 57.68 | 58.85 | 57.16 | 0.765 times |
15 Fri Aug 2025 | 57.54 | 56.92 | 59.09 | 56.45 | 0.702 times |
08 Fri Aug 2025 | 57.33 | 63.33 | 63.97 | 56.36 | 1.315 times |
01 Fri Aug 2025 | 58.14 | 59.13 | 59.62 | 56.52 | 1.535 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biomarin Pharmaceutical (BMRN)
Date | Monthly Closing Price | Open | High | Low | Volume |
29 Fri Aug 2025 | 58.27 | 57.50 | 63.97 | 56.36 | 1.136 times |
31 Thu Jul 2025 | 57.85 | 54.64 | 60.43 | 54.63 | 0.938 times |
30 Mon Jun 2025 | 54.97 | 57.99 | 58.59 | 53.72 | 0.925 times |
30 Fri May 2025 | 58.07 | 63.20 | 65.40 | 57.11 | 1.271 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biomarin Pharmaceutical (BMRN)
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 57.99 and Biomarin Pharmaceutical (BMRN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 57.99 and Biomarin Pharmaceutical (BMRN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.